Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults

Psychopharmacology

Volumn 228, Issue 4, 2013, Pages 673-683

  Harel, Brian T ^a   Pietrzak, Robert H ^b   Snyder, Peter J ^c,d   Maruff, Paul ^a,e  

^a Scientific Division   (Australia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Lifespan   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acetylcholinesterase inhibitor; Cognition; Donepezil; Executive function; Memory; Paired associate learning; Scopolamine

Indexed keywords

ACETYLCHOLINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; SCOPOLAMINE;

ADULT; ARTICLE; BLURRED VISION; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; EXECUTIVE FUNCTION; FATIGUE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; MEMORY CONSOLIDATION; NAUSEA; NORMAL HUMAN; PAIRED ASSOCIATE LEARNING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPATIAL LEARNING; TIME; TREATMENT OUTCOME; VISUAL DISCRIMINATION; VISUAL SPATIAL PAIRED ASSOCIATE LEARNING; VOLUNTEER; XEROSTOMIA;

ADOLESCENT; ADULT; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; HUMANS; INDANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIRED-ASSOCIATE LEARNING; PIPERIDINES; SCOPOLAMINE HYDROBROMIDE; TIME FACTORS; YOUNG ADULT;

EID: 84881250518     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3072-2     Document Type: Article

References (55)

1. Barch DM, Carter CS, Arnsten A et al (2009) Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 35:109-114
2. Bartko SJ, Vendrell I, Saksida LM, Bussey TJ (2011) A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Psychopharmacology (Berl) 214:537-548
3. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Psychol 47:211-218
4. Bierer LM, Haroutunian V, Gabriel S et al (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64:749-760
5. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR (2004) Detecting dementia: Novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 17:42-48
6. Blumenfeld RS, Ranganath C (2007) Prefrontal cortex and long-term memory encoding: an integrative review of findings from neuropsychology and neuroimaging. Neuroscientist 13:280-291
7. Bohme GA, Letchworth SR, Piot-Grosjean O et al (2004) In vitro and in vivo characterization of TC-1827, a novel brain alpha4beta2 nicotinic receptor agonist with pro-cognitive activity. Drug Development Research 62:26-40
8. Brasted PJ, Bussey TJ, Murray EA, Wise SP (2003) Role of the hippocampal system in associative learning beyond the spatial domain. Brain 126:1202-1223
9. Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE (2008) The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology (Berl) 199:481-494
10. Cachard-Chastel M, Devers S, Sicsic S, Langlois M, Lezoualc'h F, Gardier AM, Belzung C (2008) Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behav Brain Res 187:455-461
11. Carter CS, Barch DM, Buchanan RW et al (2008) Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry 64:4-10
12. Chan WK, Wong PT, Sheu FS (2007) Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 52:1641-1649
13. Cho W, Maruff P, Connell J et al (2011) Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans. Psychopharmacology (Berl) 218:513-524
14. Deiana S, Platt B, Riedel G (2011) The cholinergic system and spatial learning. Behav Brain Res 221:389-411
15. DeLuca J, Diamond BJ (1995) Aneurysm of the anterior communicating artery: a review of neuroanatomical and neuropsychological sequelae. J Clin Exp Neuropsychol 17:100-121
16. Dimitrov M, Granetz J, Peterson M, Hollnagel C, Alexander G, Grafman J (1999) Associative learning impairments in patients with frontal lobe damage. Brain Cogn 41:213-230
17. Drever BD, Riedel G, Platt B (2011) The cholinergic system and hippocampal plasticity. Behav Brain Res 221:505-514
18. Easton A, Douchamps V, Eacott M, Lever C (2012) A specific role for septohippocampal acetylcholine in memory? Neuropsychologia 50:3156-3168
19. Ebert U, Siepmann M, Oertel R, Wesnes KA, Kirch W (1998) Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. J Clin Pharmacol 38:720-726
20. Flicker C, Serby M, Ferris SH (1990) Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl) 100:243-250
21. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ (2002) Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc 8:58-71
22. Fredrickson A, Snyder PJ, Cromer J, Thomas E, Lewis M, Maruff P (2008) The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Hum Psychopharmacol 23:425-436
23. Furey ML, Ricciardi E, Schapiro MB, Rapoport SI, Pietrini P (2008) Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory. J Cogn Neurosci 20:1342-1353
24. Gaffan D, Parker A, Easton A (2001) Dense amnesia in the monkey after transection of fornix, amygdala and anterior temporal stem. Neuropsychologia 39:51-70
25. Ginani GE, Tufik S, Bueno OF, Pradella-Hallinan M, Rusted J, Pompéia S (2011) Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning. J Psychopharmacol 25:1508-1516
26. Giocomo LM, Hasselmo ME (2007) Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback. Mol Neurobiol 36:184-200
27. Gold P (2003) Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80:194-210
28. Grön G, Kirstein M, Thielscher A, Riepe MW, Spitzer M (2005) Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology (Berl) 182:170-179
29. Harel BT, Darby D, Pietrzak RH, Ellis KA, Snyder PJ, Maruff P (2011) Examining the nature of impairment in visual paired associate learning in amnestic mild cognitive impairment. Neuropsychology 25:752-762
30. Hasselmo ME, Stern CE (2006) Mechanisms underlying working memory for novel information. Trends Cogn Sci 10:487-493
31. Howe MN, Price IR (2001) Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr 13:465-475
32. Kay GG, Maruff P, Scholfield D, Malhotra B, Whelan L, Darekar A, Martire DL (2012) Evaluation of cognitive function in healthy older subjects treated with fesoterodine. Postgrad Med 124:7-15
33. Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, Clody DE, Burnett AL (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28:542-551
34. Koller G, Satzger W, Adam M, Wagner M, Kathmann N, Soyka M, Engel R (2003) Effects of scopolamine on matching to sample paradigm and related tests in human subjects. Neuropsychobiology 48:87-94
35. Lenz RA, Baker JD, Locke C, Rueter LE, Mohler EG, Wesnes K, Abi-Saab W, Saltarelli MD (2012) The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology (Berl) 220:97-107
36. Lever C, Burton S, O'Keefe J (2006) Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci 17:111-133
37. Lim YY, Ellis KA, Pietrzak RH et al (2012) Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 79:1645-1652
38. Lindner MD, Hogan JB, Hodges DB et al (2006) Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl) 188:629-640
39. Newman EL, Gupta K, Climer JR, Monaghan CK, Hasselmo ME (2012) Cholinergic modulation of cognitive processing: insights drawn from computational models. Front Behav Neurosci 6:24
40. O'Donnell J, Pietrzak RH, Ellis KC, Snyder PJ, Maruff P (2011) Understanding failure of visual paired associate learning in amnestic mild cognitive impairment. J Clin Exp Neuropsychol
41. Pietrzak RH, Scott JC, Harel BT, Lim YY, Snyder PJ, Maruff P (2012) A process-based approach to characterizing the effect of acute alprazolam challenge on visual paired associate learning and memory in healthy older adults. Hum Psychopharmacol
42. Pike KE, Rowe CC, Moss SA, Savage G (2008) Memory profiling with paired associate learning in Alzheimer's disease, mild cognitive impairment, and healthy aging. Neuropsychology 22:718-728
43. Poreh AM (2000) The quantified process approach: an emerging methodology to neuropsychological assessment. Clin Neuropsychol 14:212-222
44. Poreh AM. (2006) The quantified process approach to neuropsychological assessment. New York
45. Poucet B, Benhamou S (1997) The neuropsychology of spatial cognition in the rat. Crit Rev Neurobiol 11:101-120
46. Power AE, Vazdarjanova A, McGaugh JL (2003) Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80:178-193
47. Robbins TW, Semple J, Kumar R et al (1997) Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology (Berl) 134:95-106
48. Rogers JL, Kesner RP (2003) Cholinergic modulation of the hippocampus during encoding and retrieval. Neurobiol Learn Mem 80:332-342
49. Rusted JM, Warburton DM (1988) The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) 96:145-152
50. Shimamura AP, Jurica PJ, Mangels JA, Gershberg FB, Knight RT (1995) Susceptibility to memory interference effects following frontal lobe damage: Findings from tests of paired-associate learning. J Cogn Neurosci 7:144-152
51. Snyder PJ, Bednar MM, Cromer JR, Maruff P (2005) Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor. Alzheimer's & Dementia 1:126-135
52. Swainson R, Hodges JR, Galton CJ et al (2001) Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12:265-280
53. Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH (2002) Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys. Psychopharmacology (Berl) 160:253-262
54. Thomas E, Snyder PJ, Pietrzak RH, Jackson CE, Bednar M, Maruff P (2008) Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuropsychologia 46:2476-2484
55. Voss B, Thienel R, Reske M, Habel U, Kircher T (2010) Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade. Eur Arch Psychiatry Clin Neurosci 260(Suppl 2):S106-S110